Sirolimus Eluting Coronary Stent System
- UID
- IMP/MD/2019/000188_dd9e936185c45bb38483da5470752fd4_fd59303bd7b79ab8d33ed3e9a31facd7
- Device class
- Class D
- Brand name
- AMICATH II
- License holder
- EVENT MEDI SYSTEMS
- Approving authority
- CDSCO
- Product information
- ihtDEStiny Sirolimus Eluting Coronary Stent System, is indicated for use in percutaneous transluminal coronary angioplasty (AMICATH II) for permanent dilation of the stenotic part of a native coronary artery, through the placement of a coronary stent in order to improve myocardial perfusion
Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000188_dd9e936185c45bb38483da5470752fd4_fd59303bd7b79ab8d33ed3e9a31facd7. This device is marketed under the brand name AMICATH II. The license holder is EVENT MEDI SYSTEMS, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.